Literature DB >> 29705246

Profilin-mediated food-induced allergic reactions are associated with oral epithelial remodeling.

Domenico Rosace1, Cristina Gomez-Casado1, Paloma Fernandez1, Marina Perez-Gordo2, María Del Carmen Dominguez3, Angel Vega3, María Teresa Belver4, Tania Ramos4, Francisco Vega4, Guadalupe Marco5, Manuel de Pedro5, Leticia Sanchez5, María de Las Mercedes Arnas6, Marcela Santaolalla6, Miguel Ángel Saez7, Sara Benedé8, Montserrat Fernandez-Rivas5, Carlos Blanco4, Maria Isabel Alvarado3, María M Escribese9, Domingo Barber1.   

Abstract

BACKGROUND: In areas of high exposure to grass pollen, allergic patients are frequently sensitized to profilin, and some experience severe profilin-mediated food-induced reactions. This specific population of patients is ideal to study the relationship between respiratory and food allergies.
OBJECTIVE: We sought to determine the role of oral mucosal epithelial barrier integrity in profilin-mediated allergic reactions.
METHODS: Thirty-eight patients with profilin allergy stratified into mild or severe according to their clinical history and response to a profilin challenge test and 6 nonallergic subjects were recruited. Oral mucosal biopsies were used for measurement of CD11c, CD3, CD4, tryptase, claudin-1, occludin, E-cadherin, and vascular endothelial growth factor A levels; Masson trichrome staining; and POSTN, IL33, TPSAB, TPSB, and CMA gene expression analysis by using quantitative RT-PCR. Blood samples were used for basophil activation tests.
RESULTS: Distinct features of the group with severe allergy included the following: (1) impaired epithelial integrity with reduced expression of claudin-1, occludin, and E-cadherin and decreased numbers of epithelial cells, which is indicative of acanthosis, higher collagen deposition, and angiogenesis; (2) inflammatory immune response in the mucosa, with an increased number of CD11c+ and CD4+ infiltrates and increased expression of the cytokine genes POSTN and IL33; and (3) a 10-fold increased sensitivity of basophils to profilin.
CONCLUSIONS: Patients with profilin allergy present with significant damage to the oral mucosal epithelial barrier, which might allow profilin penetration into the oral mucosa and induction of local inflammation. Additionally, severely allergic patients presented with increased sensitivity of effector cells.
Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergy; epithelial remodeling; grass pollen; inflammation; oral mucosa; profilin

Mesh:

Substances:

Year:  2018        PMID: 29705246     DOI: 10.1016/j.jaci.2018.03.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  12 in total

Review 1.  Lipid Ligands and Allergenic LTPs: Redefining the Paradigm of the Protein-Centered Vision in Allergy.

Authors:  Zulema Gonzalez-Klein; Diego Pazos-Castro; Guadalupe Hernandez-Ramirez; Maria Garrido-Arandia; Araceli Diaz-Perales; Jaime Tome-Amat
Journal:  Front Allergy       Date:  2022-05-19

2.  Non-specific lipid-transfer proteins: Allergen structure and function, cross-reactivity, sensitization, and epidemiology.

Authors:  Isabel J Skypala; Ricardo Asero; Domingo Barber; Lorenzo Cecchi; Arazeli Diaz Perales; Karin Hoffmann-Sommergruber; Elide A Pastorello; Ines Swoboda; Joan Bartra; Didier G Ebo; Margaretha A Faber; Montserrat Fernández-Rivas; Francesca Gomez; Anastasios P Konstantinopoulos; Olga Luengo; Ronald van Ree; Enrico Scala; Stephen J Till
Journal:  Clin Transl Allergy       Date:  2021-05-18       Impact factor: 5.871

Review 3.  Oral Mucosa as a Potential Site for Diagnosis and Treatment of Allergic and Autoimmune Diseases.

Authors:  Cristina Gomez-Casado; Javier Sanchez-Solares; Elena Izquierdo; Araceli Díaz-Perales; Domingo Barber; María M Escribese
Journal:  Foods       Date:  2021-04-28

Review 4.  The functional biology of peanut allergens and possible links to their allergenicity.

Authors:  Peggy Ozias-Akins; Heimo Breiteneder
Journal:  Allergy       Date:  2019-02-01       Impact factor: 13.146

Review 5.  Metabolomics strategies to discover new biomarkers associated to severe allergic phenotypes.

Authors:  Domingo Barber; Alma Villaseñor; Maria M Escribese
Journal:  Asia Pac Allergy       Date:  2019-10-28

6.  GRAZAX®: a sublingual immunotherapy vaccine for Hay fever treatment: from concept to commercialization.

Authors:  Domingo Barber; Pilar Rico; Carlos Blanco; Montserrat Fernandez-Rivas; Maria Dolores Ibañez; Maria M Escribese
Journal:  Hum Vaccin Immunother       Date:  2019-06-20       Impact factor: 3.452

7.  Celiac Disease Causes Epithelial Disruption and Regulatory T Cell Recruitment in the Oral Mucosa.

Authors:  Javier Sanchez-Solares; Luis Sanchez; Carmela Pablo-Torres; Celso Diaz-Fernandez; Poul Sørensen; Domingo Barber; Cristina Gomez-Casado
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

8.  Exploring novel systemic biomarker approaches in grass-pollen sublingual immunotherapy using omics.

Authors:  Tomas Clive Barker-Tejeda; Raphaelle Bazire; David Obeso; Leticia Mera-Berriatua; Domenico Rosace; Sonia Vazquez-Cortes; Tania Ramos; Maria Del Pilar Rico; Tomás Chivato; Coral Barbas; Alma Villaseñor; Maria M Escribese; Montserrat Fernández-Rivas; Carlos Blanco; Domingo Barber
Journal:  Allergy       Date:  2020-09-22       Impact factor: 13.146

9.  Persistent regulatory T-cell response 2 years after 3 years of grass tablet SLIT: Links to reduced eosinophil counts, sIgE levels, and clinical benefit.

Authors:  Rosa Varona; Tania Ramos; Maria Marta Escribese; Lucia Jimeno; Agustin Galán; Peter A Würtzen; Francisco Vega; Alicia Marín; Santiago Martín; Ana C Carrera; Carlos Blanco; Domingo Barber
Journal:  Allergy       Date:  2018-10-11       Impact factor: 13.146

10.  T and B Lymphocyte Transcriptional States Differentiate between Sensitized and Unsensitized Individuals in Alpha-Gal Syndrome.

Authors:  Onyinye I Iweala; Shailesh K Choudhary; Claire T Addison; Scott P Commins
Journal:  Int J Mol Sci       Date:  2021-03-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.